Serum apelin-13 levels and total oxidant/antioxidant status of patients with Alzheimer’s disease

dc.contributor.author	Yildiz, Z.
dc.contributor.author	Eren, N.
dc.contributor.author	Orcun, A.
dc.contributor.author	Münevver, Gokyigit, F.
dc.contributor.author	Turgay, F.
dc.contributor.author	Gündogdu, Celebi, L.
dc.date.accessioned	2021-12-21T08:40:29Z
dc.date.available	2021-12-21T08:40:29Z
dc.date.issued	2021
dc.identifier.issn	24750360
dc.identifier.uri	https://doi.org/10.1002/agm2.12173
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1011
dc.description.abstract	Objective: We aimed to evaluate apelin-13 levels, total oxidant/antioxidant status in Alzheimer’s disease (AD) and to investigate the relationship between these parameters. Methods: Patients newly diagnosed with AD were enrolled in the study. The control
dc.language.iso	English
dc.publisher	John Wiley and Sons Inc
dc.rights	All Open Access, Gold, Green
dc.title	Serum apelin-13 levels and total oxidant/antioxidant status of patients with Alzheimer’s disease
dc.type	Article
dc.relation.journal	Aging Medicine
dc.identifier.issue	3
dc.identifier.startpage	201
dc.identifier.endpage	205
dc.identifier.volume	4
dc.identifier.doi	10.1002/agm2.12173
dc.relation.issue	3
dc.relation.volume	4

Files in this item

Files	Size	Format	View
There are no files associated with this item.